Wednesday 1/22/25 update:

We’re open regular hours at all ARC Clinics

New changes to ARC text messages

Text messages regarding appointment confirmations, personal health, and registration will now come from SMS code 27903. Read more.

MyChart Login Help Me Book

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study

Austin Regional Clinic physicians constantly work to improve the care given to all our patients. We are dedicated to offering unique options for our patients and helping them reach their ideal health goals. Part of this dedication involves making clinical research available. Clinical research makes it possible to discover the benefits, risks, and safety of commercially available and investigational medications.

Research standards are very strict to help make studies as safe as possible. Teams of government and research experts have already reviewed each study we conduct to minimize any study risks. Austin Regional Clinic has decided to be involved in this research study because we believe it can potentially benefit our patients.

About the DELFI-L101 clinical study

Enrollment into the study will occur after informed consent and eligibility is confirmed. After enrollment, blood specimens (~40 mL) will be collected and a medical record review will be completed 12 months post-enrollment. Medical history, demographics, diagnostic reports, surgery reports, imaging reports, pathology reports, and/or other diagnostic information will also be collected.

By participating in this study, you would be contributing to the development of groundbreaking technology with the potential to benefit many people in the future. ARC is one of the many study centers in the United States participating in this research study.

What to expect

Study informed consent. Blood specimens (~40 mL) will be collected and medical record review will be completed 12 months’ post-enrollment. Medical history, demographics, diagnostic reports, surgery reports, imaging reports, pathology reports, and/or other diagnostic information will also be collected.

Eligibility criteria

All participants must:

  1. Have the ability to understand and provide written informed consent
  2. Be ≥ 50 years of age
  3. Be a current or former smoker
  4. Smoke ≥ 20 pack-years (pack years = number of packs per day X number
    of years smoked)

Location

Request to participate

Please contact our ARC Clinical Research team to request to participate by calling 737-247-7240.